{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Beam Therapeutics Inc."},"Symbol":{"label":"Symbol","value":"BEAM"},"Address":{"label":"Address","value":"238 MAIN STREET,9TH FLOOR, CAMBRIDGE, Massachusetts, 02142, United States"},"Phone":{"label":"Phone","value":"+1 857 327-8775"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing."},"CompanyUrl":{"label":"Company Url","value":"https://www.beamtx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Amy Simon","title":"Chief Medical Officer"},{"name":"Gopi Shanker","title":"Chief Scientific Officer"},{"name":"John Evans","title":"Chief Executive Officer, CFO, CAO & Director"},{"name":"Manmohan Singh","title":"Chief Technology Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}